~~<i id='0002785631'><strike id='0002785631'><tt id='0002785631'><pre id='0002785631'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

Wikipedia

author：explore 2025-09-07 04:09:52 - browse：7933

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： The thinking behind the controversial eating disorder chatbot Tessa

Wikipedia

hotspot

entertainment

focus

explore

knowledge

IftherewasonemomentthatledKathleenBachynskitoacareerstudyingthepublichealthsignificanceofsportsinjur

WSS

Pharma budget tightening trickles down to Doximity

Eli Lilly’s Mounjaro succeeds in second weight

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Can medical device makers keep up in the race to treat obesity?

Where are patients getting their prescriptions for GLP

TB outbreak tied to bone grafts underscores testing shortcomings

entertainment

Wikipedia

Wikipedia

State Dept. review finds Biden bears some blame for Afghanistan failures

Bispecific antibodies are next new thing in cancer immunotherapy

New air purifier tech could be key to improving indoor air quality

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

United colonoscopy coverage change 'may cost lives,' doctors say

Living organ donors deserve priority status for transplants

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Living organ donors deserve priority status for transplants

New air purifier tech could be key to improving indoor air quality

Newly revealed memo details efforts to keep Trump in power following election loss

hotspot

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

After John Oliver segment, STAT readers share their opioid

Can medical device makers keep up in the race to treat obesity?

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Altering the blood type of lungs raises potential for universal organs for transplants

entertainment

focus

explore

knowledge